| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2004-09-01^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efe8029bf64670e0e4921f74f44bb678
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_254c53125066b396430dce74dcda8055 |
| publicationDate |
2007-05-10^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007104687-A1 |
| titleOfInvention |
AAV vectors for in vivo gene therapy of rheumatoid arthritis |
| abstract |
The present invention relates to the field of adeno-associated virus (AAV) based gene therapy, in particular in vivo gene therapy, of rheumatoid arthritis (RA). The invention provides recombinant AAV virions being highly efficient in delivering genes encoding therapeutic proteins to the arthritic joints, and method for using such virions in in vivo gene therapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110024752-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112004544-A |
| priorityDate |
2003-09-01^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |